Taming The TGF-β Double-Edged Sword for Tumor Suppression, Navigating a Narrow Therapeutic Window for Clinical Translation & Maximizing Therapeutic .. Read more Potential in IO. Exploring the wide array of approaches being utilized in pharma, biotech, and academia, the TGFβ for Immuno-Oncology Drug Development Summit is the ONLY industry-led event dedicated exclusively to exploring TGF-beta's role in cancer therapeutics. This 3-day summit is your definitive meeting to delve into the core challenges of this complex target. Don't miss out on your chance to deepen your understanding of cell signaling mechanisms, change your view of the tumor microenvironment, and prepare your candidates for the clinic to ensure patient safety.
- Share your Experience